Mesenchymal stem cells (MSCs) can differentiate toward epithelial cells and may be used as an alternative source for generation of heterotypical artificial human skin substitutes, thus, enhancing their development and translation potential to the clinic. The present study aimed at comparing four types of heterotypical human bioengineered skin generated using MSCs as an alternative epithelial cell source. Adipose-tissue-derived stem cells (ADSCs), dental pulp stem cells (DPSCs), Wharton's jelly stem cells (WJSCs) and bone marrow stem cells (BMSCs) were used for epidermal regeneration on top of dermal skin substitutes. Heterotypic human skin substitutes were evaluated before and after implantation in immune-deficient athymic mice for 30 d. Histological and genetic studies were performed to evaluate extracellular matrix synthesis, epidermal differentiation and human leukocyte antigen (HLA) molecule expression. The four cell types differentiated into keratinocytes, as shown by the expression of cytokeratin 10 and filaggrin 30 d post-grafting; also, they induced dermal fibroblasts responsible for the synthesis of extracellular fibrillar and non-fibrillar components, in a similar way among each other. WJSCs and BMSCs showed higher expression of cytokeratin 10 and filaggrin, suggesting these cells were more prone to epidermal regeneration. The absence of HLA molecules, even when the epithelial layer was differentiated, supports the future clinical use of these substitutes -especially ADSCs, DPSCs and WJSCs -with low rejection risk. MSCs allowed the generation of bioengineered human skin substitutes with potential clinical usefulness. According to their epidermal differentiation potential and lack of HLA antigens, WJSCs should preferentially be used.
Introduction
In recent years, tissue engineering has developed as an alternative regenerative medicine approach for the clinical treatment of severe skin diseases, as it allows the efficient treatment of large and deep skin conditions Kober et al., 2016) . Numerous models of human skin, generated by tissue engineering, have been developed to date (Beaudoin Cloutier et al., 2017; Bhowmick et al., 2017; Forouzandeh et al., 2010; Hartmann-Fritsch et al., 2016; Klar et al., 2018; Larouche et al., 2016; Lloyd et al., 2015; Pensalfini et al., 2017; Reuter et al., 2017; Strong et al., 2017; Vig et al., 2017) . However, few clinical trials have been conducted to test the biological security (phase I and II assays) of human skin models (Boa et al., 2013; Boyce et al., 2006; Boyce et al., 1999; Boyce et al., 2017; Germain et al., 2018; Moravvej et al., 2016; Yamada et al., 2012) . Most of the clinically efficient skin models are organotypic structures, consisting of a dermal substitute of dermal fibroblasts immersed in biocompatible scaffolds and an epidermal layer of keratinocytes seeded on top of the stroma. These orthotypic models show high feasibility for epidermal differentiation and maturation because differentiation of epidermal cells strongly depends on epithelial-mesenchymal interactions (Smola et al., 1993) .
Development of organotypic human skin substitutes is strongly dependent on the isolation and culture of autologous cells, isolated and expanded in culture from healthy donor skin. However, healthy skin biopsies are sometimes difficult to obtain, especially when the patient is in a critical condition due to large-scale burns and concomitant infections. In addition, a major limitation of this technique is the time required for the isolated cells to generate a sufficient number of cells for tissue engineering, especially in the case of keratinocytes. On the other hand, epidermal keratinocytes are terminally differentiated cells that are difficult to handle in culture in the absence of feeder layers, proliferate slowly and tend to dedifferentiate in culture Kraft et al., 2012) . For all these reasons, alternative cell sources allowing for the generation of human skin substitutes, without the drawbacks associated with skin biopsies, are needed for an optimal clinical translation (Bhardwaj et al., 2017) .
Mesenchymal stem cells (MSCs) are adult cells with proliferation and differentiation capabilities, showing adherence to plastic, expression of specific surface markers and multipotent differentiation potential into adipocyte, chondrocyte and osteoblast lineages (Dominici et al., 2006; Kim and Park, 2017; Pittenger et al., 1999) . MSCs are excellent candidates for tissue engineering applications due to their unique properties. MSCs have been described in a wide variety of human adult tissues (Gimble and Guilak, 2003) . However, the four main sources of MSCs in humans are adipose-tissue-derived stem cells (ADSCs) (Zuk et al., 2002) , dental pulp stem cells (DPSCs) (Gronthos et al., 2000) , umbilical cord Wharton's jelly stem cells (WJSCs) (Wang et al., 2004) and bone marrow stem cells (BMSCs) (Friedenstein et al., 1976; Pittenger et al., 1999) . In addition to adipocyte, chondrocyte and osteoblast differentiation potential, MSCs have epithelial differentiation capability and heterotypical models of artificial tissues could be generated using MSCs as alternative cell sources (Garzon et al., 2013) . In this regard, preliminary reports support the epithelial differentiation capability of ADSCs (Baer et al., 2013) and human tooth-derived stem cells (Dogan et al., 2015) . In turn, WJSCs are efficiently differentiated into cornea epithelial cells and human skin as well as oral mucosa keratinocytes (Garzon et al., 2013) . BMSCs, the most characterised MSC source, can differentiate into several types of epithelial cells, including skin keratinocytes (Kokubun et al., 2016; Mahdavishahri et al., 2012; Mendez et al., 2014; Wang et al., 2014; Zhang et al., 2012) . Although these previous reports support the epithelial potential of MSCs, there are no studies comparing the keratinocytic differentiation capability of the four main MSC sources for skin tissue engineering.
When compared with skin keratinocyte cultures, MSCs have important advantages, including accessibility, high proliferation rate and easy culturing, as well as very low risk of malignant transformation after allogeneic transplantation as compared to embryonic stem cells (ESCs) or induced pluripotent stem cells (iPS) (Kim and Park, 2017) . In addition, one of the striking properties of MSCs, from a translational point of view, is that these cells are immunoprivileged due to the low expression of human leukocyte antigen (HLA) complex molecules and may have immunomodulatory properties (Castro-Manrreza and Montesinos, 2015; Losk et al., 2016; Shi et al., 2011) . Several studies have demonstrated that MSCs can be grafted into a host patient with a low rejection risk (Casiraghi et al., 2008; Reinders et al., 2013) . In this sense, development of human skin models using allogeneic MSCs differentiated into epidermal keratinocytes could prevent the above-described shortcomings derived from generation of autologous skin models. Thus, easier and faster generation of heterotypical models could be an advantageous approach for the translation of these advanced-therapy products as a therapeutical choice.
The aim of the present study was to compare four different models of heterotypical human bioengineered skin generated by using ADSCs, DPSCs, WJSCs and BMSCs as alternative epithelial cell sources. These models were evaluated in vitro or in vivo to determine the potential clinical usefulness of heterotypical human skin substitutes.
Materials and Methods

Generation of MSC primary cell cultures
To generate primary cell cultures of human dermis fibroblasts, skin biopsies were obtained from healthy donors. To generate primary cultures of ADSCs, WJSCs and BMSCs, small biopsies were obtained from adipose tissue, umbilical cord and bone marrow, as previously described (Alfonso-Rodriguez et al., 2015; Cejka et al., 2016; Dori et al., 2017) . To generate DPSC cultures, extracted sound third molars were obtained (Garzon et al., 2017) . In all cases, tissues were obtained from healthy donors subjected to surgical procedures not related to the present study. All patients gave informed consent and the study was approved by the Research and Ethics Committee of the Health System of Granada Hospitals, Spain.
Upon arrival at the laboratory, tissues were washed in phosphate-buffered saline (PBS), dissected to isolate tissues rich in MSCs and enzymatically digested for 6 h at 37 °C under slight agitation with a 2 mg/mL solution of Clostridium histolyticum type I collagenase (Gibco). Isolated human dermal fibroblasts and ADSCs, DPSCs and BMSCs were cultured in Dulbecco's modified Eagle's medium (DMEM; Sigma-Aldrich) supplemented with 10 % foetal bovine serum (Sigma-Aldrich) and 1 % antibiotic and antimycotics (100 U/mL penicillin G, 100 mg/ mL streptomycin and 0.25 mg/mL anphoterycin B; Sigma-Aldrich) under standard culture conditions. WJSCs were cultured in AmnioMAX™ medium (Gibco), as previously reported (Alfonso-Rodriguez et al., 2015) . Culture medium was changed three www.ecmjournal.org times a week and cells were dissociated with 0.25 % trypsin-ethylenediaminetetraacetic acid (EDTA; Sigma-Aldrich) before reaching confluence.
Generation of human heterotypic skin (HHS)
HHS was developed using 24 mm Transwell ® porous inserts with polycarbonate membranes with a pore size of 0.4 µm (Costar, Corning Inc.). Briefly, a stromal substitute was generated using a mixture of human fibrin obtained from frozen plasma (Human Tissue Bank of Granada, Spain) and 0.1 % type VII agarose in PBS. To produce a 5 mL dermal substitute, 3.8 mL of human plasma were added to 375 µL of DMEM with 500,000 cultured skin fibroblasts. To prevent gel fibrinolysis, the mixture was supplemented with 75 µL of tranexamic acid (Amchafibrin, Fides Ecopharma, Barcelona, Spain). Then, 500 µL of 1 % CaCl 2 were added to induce fibrin polymerisation, followed by immediate addition of 250 µL of melted concentrated agarose (2 % in PBS) at 40 °C. The final concentration of agarose in the stromal substitute was 0.1 %. Finally, the mixture was rapidly aliquoted on porous inserts and allowed to solidify at 37 °C for 2 h. 24 h after the stroma had solidified, 250,000 MSCs were seeded on top of the stromal layer to generate an epithelial-like layer consisting of each MSC type in order to generate ADSC-HHS, DPSC-HHS, WJSC-HHS and BMSC-HHS substitutes. All HHS were cultured for 7 d submerged in culture medium and cultured for 21 d following an airliquid culture technique to induce epithelial differentiation (4 weeks in total). Heterotypic artificial skin substitutes were cultured in keratinocyte inductive medium consisting of a 3 : 1 mixture of DMEM and HAM's F12 culture medium supplemented with 10 % foetal bovine serum (FBS), 1 % antibiotic/antimycotic solution, 24 µg/mL adenine, 0.4 µg/mL hydrocortisone, 5 µg/mL insulin, 10 ng/µL epidermal growth factor and 1.3 ng/mL triiodothyronine (all reagents were purchased from Sigma-Aldrich).
In vivo evaluation
To evaluate them in vivo, HHS were grafted in 6-weekold immune-deficient athymic nude Foxn1nu mice (Envigo, Huntingdon, UK) (Fig. 1) . Briefly, mice were anesthetised using a mixture of 0.001 mg/g of bodyweight of acepromazine (Calmo-Neosan, Boehringer Ingelheim, Ingelheim am Rhein, Germany) and 0.15 mg/g of body-weight of ketamine (Imalgene 1000, Merial labs, Barcelona, Spain). Then, a skin area of 20 mm in diameter was surgically removed from the dorsal area of each animal and the HHS was trimmed to the same diameter. HHS samples were grafted at the injury site using absorbable suture material. A plastic ring was implanted at the injury borders and sutured using the same suture material to prevent the host skin from shrinking; the plastic ring was carefully removed after 10 d post-grafting. Only one graft HHS was implanted per mouse. Mice were euthanised 15 or 30 d after implantation of the bioengineered tissues, for histological analysis of grafted HHS and surrounding native skin. 4 mice per MSC group (ADSCs, DPSCs, WJSCs and BMSCs) were used.
Histological analyses
Control native human skin (NHS) and HHS kept in vitro (for 1, 2 and 4 weeks) and grafted in vivo (for 15 and 30 d) were fixed in 4 % formaldehyde for 24 h at 4 °C and embedded in paraffin. 5 µm-thick tissue sections were stained with haematoxylin-eosin for histological analysis. 5 independent sample replicates were analysed per group.
To evaluate the synthesis of extracellular matrix (ECM) components in the bioengineered dermis, the presence of collagen fibres, glycosaminoglycans (GAGs) and proteoglycans was assessed by histochemistry. First, the presence of collagen fibres was evaluated by picrosirius red histochemistry using Sirius red F3B (Sigma-Aldrich) for 30 min, as previously described . Fibre organisation was assessed by polarised light microscopy. To identify the presence of glycoproteins in the HHS, the Schiff periodic acid histochemical method (PAS), with Harris's haematoxylin counterstaining for 1 min, was used. Finally, samples were incubated in alcian blue histochemical solution for 30 min and counterstained with nuclear fast red solution for the detection of extracellular proteoglycans .
Epithelial layer analysis was performed by immunofluorescence for the epidermal markers cytokeratin 5 (CK5), cytokeratin 10 (CK10) and filaggrin (FGN). Briefly, tissue sections were deparaffinised and rehydrated before antigen retrieval with citrate buffer for 20 min at 95 °C. Then, samples were prehybridised with normal horse serum (Vector Laboratories) for 1 h and incubated with prediluted anti-CK5 and anti-CK10 (Master Diagnostica, Granada, Spain) or 1 : 50 anti-FGN (Abcam) primary 
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Mesenchymal heterotypical bioartificial skin antibodies overnight at 4 °C. Anti-mouse secondary antibodies conjugated with fluorescein isothiocyanate (FITC; Sigma-Aldrich) were used at a 1 : 500 dilution. Sections were counterstained with mounting medium containing 4′,6-diamidino-2-phenylindole (DAPI; Vector Laboratories).
To identify the presence of major histocompatibility complex molecules, routine immunohistochemical methods were used. First, samples were dewaxed and rehydrated and endogenous peroxidase was quenched with H 2 O 2 . Then, tissues were prehybridised and incubated with primary antibodies against type I HLA (HLA I) and type II HLA (HLA II) diluted at 1 : 200 (Santa Cruz Biotech). Positive signal was visualised using 3, 3-diaminobenzidine (DAB; Vector Laboratories) and tissue sections were counterstained for 15 s with Harris's haematoxylin.
In all cases, light microscopy images were obtained using an Eclipse 90i microscope (Nikon). Results of the histochemical and immunohistochemical analyses were semi-quantitatively analysed as previously described Garzon et al., 2009b) . Staining was categorised as strong (+++), mild (++), slight (+) or negative (−). The expression was also stated following the topograpycal location of the signal as basal layer (
. In all cases, average results corresponding to the analysis of 5 replicate samples were obtained.
Preliminary gene expression analysis
To determine the putative differentiation potential of each MSC type, ADSCs, DPSCs, WJSCs and BMSCs were kept in culture in basal medium (DMEM supplemented with 10 % foetal calf serum and antibiotics-antimycotics) or epithelial induction medium (QC) for 28 d. Then, total RNA was isolated from each cell culture using RNeasy Mini Kit (Qiagen) and retrotranscribed to cDNA using a reverse transcriptase (Superscript II, Life Technologies) and a T7-oligo(dT) primer. Biotinylated cRNA was generated using a T7 RNA polymerase and biotin-11-uridine-5'-triphosphate (Enzo Diagnostics, Farmingdale, NY, USA), chemically fragmented and hybridised to Affymetrix Human Genome U133 plus 2.0 oligonucleotide arrays (Affymetrix Inc., Santa Clara, CA, USA) for 6 h at 45 °C. 4 samples were analysed per group (n = 4). Expression levels found for each probe-set in the array were classified as present (P), marginal (M) or absent (A) for each sample by using the Affymetrix Suite software (Affymetrix Inc.). Affymetrix NetAffx Analysis Center (Affymetrix Inc.) was used to identify all genes in the array with a putative epithelial-cell-related function. All probe-sets showing an expression increase after QC induction (for example, an absent gene in cells cultured with basal medium that became present upon QC culturing) were selected for each MSC type. To determine the gene functions associated with selected probe-sets, BiNGO gene ontology analysis (Ghent University, Belgium) was used as previously described (Maere et al., 2005) .
Results
Gene expression analysis
Preliminary gene expression analysis suggested that QC differentiation medium induced the expression of several genes in the 4 MSC types evaluated (Raw Data file 1). Out of the 54,613 array probe-sets, 4,351 (7.97 % of all probe-sets) became upregulated upon induction in ADSCs, with 172 being identified as epithelial genes. For WJSCs, 3,670 probe-sets (6.72 %) were upregulated, with 184 corresponding to epithelial genes. When BMSCs were analysed, 2,913 probe-sets (5.33 %) were upregulated, with 103 being identified as epithelial genes. Finally, 2,545 probe-sets (4.66 %) were upregulated in DPSCs, with 106 corresponding to epithelial genes. BiNGO gene ontology analysis identified 98 gene functions associated with all probe-sets activated in ADSCs, 76 in WJSCs and 23 in BMSCs and DPSCs (Raw Data 2 file). Although most 'GO' gene functions corresponded to unspecific cell components and cell physiology, some of these functions were associated with cell adhesion and cell-cell junctions.
In vitro and in vivo histological analysis
In vitro generation of HHS substitutes using ADSCs, DPSCs, WJSCs and BMSCs allowed for the development of an epithelial-like layer from the first week of culture in all study groups (Fig. 2) . HHS generated using transdifferentiated ADSCs and DPSCs were able to form an epithelium-like structure composed of a single cell layer along the 4 weeks of in vitro culture without any sign of terminal differentiation.
Grafting of HHS for the treatment of skin wounds did not generate any signs of inflammation, necrosis or other harmful effects. After 15 d post-grafting, wound diameter showed an average contraction of 45 % as compared to the original injury for all experimental groups and 61.7 % after 30 d (Fig. 1) . However, after in vivo grafting, both cell populations induced the generation of up to 10 epithelial-like layers after 15 and 30 d. Haematoxylin-eosin histological In vitro and in vivo evaluation of the dermal substitute The dermal substitute was mainly composed of cellular and extracellular components. A spindleshape cell population was found in all in vitro HHS substitutes and the cell number tended to increase once grafted in vivo (Fig. 2) . The ECM is mainly composed of fibrillar and nonfibrillar molecules. In terms of fibrillar components, collagen fibres were identified by picrosirius red staining (Fig. 4 Immunogenic potential
In vitro and in vivo expression of skin epithelial markers CK5 expression was negative in vitro in ADSCs and DPSCs and positive in all layers after in vivo implantation. Moreover, WJSCs were slightly positive for CK5 expression after 4 weeks of in vitro development and signal notably increased after 15 and 30 d of implantation, resembling the expression pattern of native human skin -with positive expression mainly in the basal layer (Fig. 7 Fig. 10 and 11 , Table 1 ).
Discussion
The skin is the largest organ of the human body. It serves as an effective barrier between the organism and the environment and is involved in the regulation of body temperature and fluid loss (Proksch et al., 2008) . Among the main conditions severely affecting the human skin, burns are serious therapeutical situations for which a fully valid management approach is not clinically available. In fact, treatment of deep burn-wounds is based on the use of autografts, which are not available in cases where large areas of skin are affected. Recently, tissue engineering has emerged as a therapeutic alternative, allowing the generation of autologous full-thickness skin substitutes for the treatment of deep burnwounds and showing promising results (Llames et al., 2004) . Development of heterotypical artificial skin models would contribute to overcome the drawbacks associated with the generation of bioengineered skin. The use of MSCs as alternative cell sources offers several potential advantages such as availability, proliferation and differentiation capability with low immunogenic potential (Koppula et al., 2009; Weiss et al., 2008) . The lack of immunological reaction makes these cells excellent candidates for cellular therapy in an allogeneic setting (Le Blanc and Ringden, 2005) . However, a comparative study focussed on the differentiation potential of the four main sources of MSCs into skin epithelium has not been carried out to date. The present study approach was to determine the capability of each of the four MSC types to be induced using a specific epithelial conditioning medium in two-dimensional (2D) culture systems. Results showed a small number of induced genes. ADSCs and WJSCs showed larger percentages of induced genes. However, BMSCs and DPSCs were able to induce a series of genes with a putative role in epithelial cell function, such as cell adhesion. These results supported the use of the four MSC types in tissue engineering, given their epithelial differentiation capability, as previously demonstrated (Zhang et al., 2012) . In the present work, novel models of bioengineered skin generated by using four MSC types were described. In agreement with previous reports, suggesting that heterotypical bioengineered tissues have low levels of differentiation while kept in vitro (Garzon et al., 2013; Garzon et al., 2009a) , in vitro tissues had very few cell layers on top of the dermis substitute -although the number of cell layers tended to increase with time -and a complete absence of differentiation markers, such as rete ridges and chorial papillae or keratinisation. Expression of CK is one of the main features of human epidermal cells. For this reason, the first CK analysed was CK5, which is paired with CK14 and is a marker of basal proliferative keratinocytes that act as epithelial stem cells (Kim et al., 2002) . Results showed that WJSCs and BMSCs were able to express small amounts of this marker under in vitro conditions, suggesting that these cell types could respond to epithelial inductive medium more efficiently than ADSCs and DPSCs. However, the in vivo setting was able to induce the expression of CK5 in all samples, but the expression pattern tended to resemble the preferentially basal expression of native skin only in the two cell types that showed the highest differentiation potential in vitro, WJSCs and BMSCs. On the other hand, HHS generated using WJSCs and BMSCs showed mild expression of CK10 in most epithelial-like cells. The slight expression of CK10 under in vitro conditions could be linked to an early epithelial differentiation stage. However, when tissue samples were implanted in vivo, differentiation was enhanced and stratification organisation was more evident. The proper set-up of basal cells may enhance proliferation and cell differentiation into epithelial-like tissue. An interesting phenomenon was that BMSCs showed slight CK10 expression in vitro, but this expression was initially negative in vivo and became positive at 30 d. This finding may be explained as an adaptive process of the cells, which could partially lose their original orientation in vivo and, thus, minimise their expression profile until the epithelium became fully differentiated. These results, related to the in vitro differentiation potential of WJSCs and BMSCs, were in agreement with previous work demonstrating their keratinocytic differentiation capability (Garzon et al., 2013) and with the fact that ADSCs and DPSCs have not yet been differentiated into skin keratinocytes -although reports have suggested that these cell types may have epithelial differentiation capability in the presence of inductive medium (Baer et al., 2013; Dogan et al., 2015). In the present study, both WJSCs and BMSCs were able to develop a larger number of cell layers at the in vitro stage, which coincided with the early cytokeratin expression. Therefore, the use of a combined trans-differentiation protocol based on epithelial conditioning medium, 3D systems with dermal cells supporting epithelial-mesenchymal interaction and air-liquid culture technique could partially induce in vitro epidermal differentiation of some of the studied MSC types but failed to achieve terminal differentiation.
In vivo grafting was performed by using a plastic ring standardised model (Fang and Mustoe, 2008; Galiano et al., 2004) to minimise and control wound contraction. Previous studies have described contraction in mice as a common physiological phenomenon after skin grafting. Park et al. (2014) compared the use of splinted versus non-splinted models and demonstrated that the wound generated in the skin of the animal tends to fully shrink and contract after 11 d in non-splinted models, whereas splinted models reduce the contraction rate to near 60 % after 11 d (Gebremeskel et al., 2018; Park et al., 2014) . In the present study, the wound contraction percentage reached 61.7 % after 30 d, suggesting a reduction of the wound contraction that may improve re-epithelisation with the grafted tissue. These results are in accordance with a study reporting that use of silicone splints around dorsal wounds may attenuate contraction but that the final graft size is typically around 40-50 % (Galiano et al., 2004) .
Once grafted in vivo, MSCs were subjected to additional differentiation signals depending on the local and systemic inductive factors generated by the host. This resulted in higher differentiation in all cases, with the formation of terminally differentiated epithelial cell layers and other differentiation markers. Previous reports have demonstrated that the in vivo environment is necessary for the cells to fully develop and differentiate, which does not occur in vitro (Garzon et al., 2009a; Garzon et al., 2013) . One of the challenges of bioartificial tissues grafted in immunodeficient animals is demonstrating the presence of the human cells in the graft and determining the fate of the implanted cells. In the present work, human-specific antibodies were used to demonstrate that cells in the regenerated skin area were of human nature. Future studies should analyse cell migration and stability in vivo by using high-definition cell-tracking techniques (Bulte and Daldrup-Link, 2018) .
The in vitro analysis of the dermal substitute showed a complete absence of the fibrillar and nonfibrillar ECM components analysed, which tended to appear in vivo. In general, the artificial dermis grafted in vivo was able to synthesise and generate abundant amounts of collagen fibres and reached the levels of the control except for ADSCs, suggesting that the type www.ecmjournal.org of MSCs used as epithelial substitute may influence the biosynthetic activity of dermal fibroblasts. The presence of collagen fibres is very important to keep the biomechanical properties of the human skin (Aziz et al., 2016) and its presence in the dermal substitute could favour the adequate physiology and mechanical behaviour of the artificial skin. In this regard, the fibrin-agarose bioartificial human tissue substitutes share some biomechanical similarities [G' modulus ranging between 30 and 70 Pa and G'' between 40 and 50 Pa (Rodriguez et al., 2012) ] with native human tissues, although their biomechanical properties are not completely biomimetic to control tissues.
Regarding the non-fibrillar ECM components of the dermal substitute, results showed that the four types of HHC were able to synthesise GAGs, although only ADSCs were able to reach the expression levels found in the control tissues. However, proteoglycans were very abundant in the four MSC types after 30 d of development, suggesting that this important dermal component was easily generated by the dermal fibroblasts independently of the type of epithelial substitute found on top. Previous work showed that GAGs and proteoglycans are important components of the skin ECM that may facilitate wound healing, cell adhesion, migration, proliferation, metabolism, differentiation, survival and growth factor activity (Ghatak et al., 2015) . Therefore, their presence in the bioengineered skin should be a requisite for these tissues to be clinically useful and previous fibrinagarose human bioartificial skin models display high expression of these components in vivo (MartinPiedra et al., 2017) .
Results of the epithelial substitute showed that the highest epithelial differentiation potential corresponded to WJSCs and BMSCs according to CK10 expression and WJSCs according to FGN. Along with the larger number of cell layers in WJSCbased HHS, these findings would confirm previous results showing the skin-epithelium differentiation potential of WJSCs (Garzon et al., 2013) . In contrast with the other three MSC types studied, WJSCs were obtained from new-born umbilical cords. This perinatal cell source could retain some of the proliferation and differentiation capabilities of embryonic cells, which could explain their potential in tissue regeneration. WJSCs are easily accessible and have been extensively used in tissue engineering and regenerative medicine without the risk of tumorigenesis (Joerger-Messerli et al., 2016) . However, the other three MSC types also displayed differentiation potential as epithelial markers, as determined by CK10 and FGN expression analysis, and showed high expression of proteoglycans and collagen (especially DPSCs and BMSCs). Future works should determine if these four MSC types may have the potential to fully differentiate into skin epidermis by using other inductive factors or clues, other in vivo models or longer follow-up periods.
One possible issue related to the use of MSCs differentiated towards human epithelial keratinocytes is the possibility that immunopriviliged undifferentiated MSCs (Weiss et al., 2008) might acquire immunogenicity under certain conditions, including epidermal differentiation. In fact, upregulation of major histocompatibility complex (MHC)-II antigens is detected after gamma-interferon induction in MSC cultures, which could point towards this possibility (Le Blanc and Ringden, 2005) . In the present work, the four analysed MSC types were initially negative for several HLA I and HLA II markers in the HHS models. However, preliminary epithelial differentiation found in BMSC-HHS kept in vitro for 2 and 4 weeks (as determined by CK10 immunostaining) coincided with a slight expression of HLA I antigens. Nevertheless, in vivo grafting resulted in a complete absence of HLA I signal in all HHS types, although HLA II became slightly positive in BMSC-HHS after 15 and 30 d of in vivo development. The transient expression of HLA I in BMSCs kept in vitro remains intriguing and future studies should be performed to elucidate this issue. One important concern is the possibility that HHS cells could express HLA markers after full differentiation, as previously suggested for bone and cartilage tissue substitutes (Lee et al., 2012; Lohan et al., 2014; Lohan et al., 2017) . The lack of information related to HLA expression on MSCs differentiated towards epithelial cell lineages makes necessary to perform future studies using longer follow-up times.
Altogether, these results confirm the absence of immunogenic HLA markers in bioengineered human substitutes generated using ADSCs, DPSCs and WJSCs. Although the epithelial layer was differentiated and would support the future clinical use of these substitutes, BMSC-based HHS could become immunogenic for HLA II upon induction. For this reason, the preferential use of HHS based on ADSCs, DPSCs and WJSCs instead of BMSCs would be recommendable. Therefore, these results would support the use of these types of MSCs for the generation of heterotypical models of human skin, but also other bioengineered tissues or organs such as human cornea and oral mucosa.
For the clinical transference of these bioengineered skin substitutes, several steps should be achieved, including exhaustive preclinical quality control analyses fulfilling the requirements of the European Medicines Agency.
Conclusions
Results demonstrated the partial epithelial differentiation capability of ADSCs, DPSCs, WJSCs and BMSCs, which could be used for the generation of bioengineered human skin substitutes with potential clinical usefulness. However, WJSCs demonstrated the highest differentiation capability and lack of HLA MA Martin-Piedra et al.
Mesenchymal heterotypical bioartificial skin I and II expression upon induction. Therefore, WJSCs could be used for the generation of human skin substitutes. However, future studies should assess the functional properties of the skin regenerated by these substitutes and its long-term differentiation potential.
